Palmerini, Emanuela; Pasello, Michela; Jones, Robin Lewis; Manara, Maria Cristina; Fagioli, Franca; Grignani, Giovanni; Longhi, Alessandra; Cesari, Marilena; Abate, Massimo Eraldo; Paioli, Anna; Setola, Elisabetta; Hakim, Rossella; D'Ambrosio, Lorenzo; Parra, Alessandro; Sebastian, Asaftei Dorin; Righi, Alberto; Morandi, Luca; Donati, Davide Maria; Ferrari, Stefano; Scotlandi, Katia, Irinotecan and temozolomide upfront and in relapsed Ewing sarcoma: A translational study on MGMT (O6-methylguanine–DNA methyltransferase) and ABCG2 (MGMTLiberati), «JOURNAL OF CLINICAL ONCOLOGY», 2020, 38, pp. e23564 - e23564 [abstract]
Gronchi A.; Palmerini E.; Quagliuolo V.; Broto J.M.; Lopez Pousa A.; Grignani G.; Brunello A.; Blay J.-Y.; Tendero O.; Diaz Beveridge R.; Ferraresi V.; Lugowska I.; Franco Merlo D.; Fontana V.; Marchesi E.; Braglia L.; Maria Donati D.; Palassini E.; Bianchi G.; Marrari A.; Morosi C.; Stacchiotti S.; Bague S.; Coindre J.M.; Dei Tos A.P.; Picci P.; Bruzzi P.; Casali P.G., Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups, «JOURNAL OF CLINICAL ONCOLOGY», 2020, 38, pp. 2178 - 2186 [articolo]
Palmerini E.; Longhi A.; Donati D.M.; Staals E.L., Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy, «EXPERT REVIEW OF ANTICANCER THERAPY», 2020, 20, pp. 441 - 445 [articolo]
Grosso F.; D'Ambrosio L.; Zucchetti M.; Ibrahim T.; Tamberi S.; Matteo C.; Rulli E.; Comandini D.; Palmerini E.; Baldi G.G.; DeCensi A.; Bergaglio M.; Marra D.; Marchesi E.; Siri G.; D'Incalci M.; Grignani G., Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group, «CANCER», 2020, 126, pp. 4726 - 4734 [articolo]
Palmerini E.; Righi A.; Staals E.L., Rare primary malignant bone sarcomas, «CANCERS», 2020, 12, Article number: 3092, pp. 1 - 14 [articolo]Open Access
Palmerini E.; Staals E.L.; Jones L.B.; Donati D.M.; Longhi A.; Randall R.L., Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone, «CURRENT TREATMENT OPTIONS IN ONCOLOGY», 2020, 21, Article number: 68, pp. 1 - 10 [articolo]
Martin-Broto J.; Hindi N.; Aguiar S.; Badilla-Gonzalez R.; Castro-Oliden V.; Chacon M.; Correa-Generoso R.; de Alava E.; Donati D.M.; Eriksson M.; Falla-Jimenez M.; German G.; Gobo Silva M.L.; Gouin F.; Gronchi A.; Haro-Varas J.C.; Jimenez-Brenes N.; Kasper B.; Lopes de Mello C.A.; Maki R.; Martinez-Delgado P.; Martinez-Said H.; Martinez-Tlahuel J.L.; Morales-Perez J.M.; Munoz-Casares F.C.; Nakagawa S.A.; Ortiz-Cruz E.J.; Palmerini E.; Patel S.; Moura D.S.; Stacchiotti S.; Sunyach M.P.; Valverde C.M.; Waisberg F.; Blay J.-Y., Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic, «THE ONCOLOGIST», 2020, 25, pp. e1562 - e1573 [articolo]Open Access
Palmerini, E; Leithner, A; Windhager, R; Gosheger, G; Boye, K; Laitinen, M; Hardes, J; Traub, F; Jutte, P; Willegger, M; Casanova, J; Setola, E; Righi, A; Picci, P; Donati, DM; Ferrari, S, Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study, «JOURNAL OF CLINICAL ONCOLOGY», 2019, 37, pp. 1 - 1 [abstract]
Cesari M.; Righi A.; Colangeli M.; Gambarotti M.; Spinnato P.; Ferraro A.; Longhi A.; Abate M.E.; Palmerini E.; Paioli A.; Ferrari C.; Donati D.M.; Picci P.; Ferrari S., Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution, «PEDIATRIC BLOOD & CANCER», 2019, 66, Article number: e27653, pp. e27653 - N/A [articolo]
Ferrari S.; Palmerini E., Chemotherapy of Ewing Sarcoma, in: Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - the Rizzoli Case Archive, Cham, Springer International Publishing, 2019, pp. 237 - 239 [capitolo di libro]
Ferrari S.; Palmerini E., Chemotherapy of Osteosarcoma, in: Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - the Rizzoli Case Archive, Cham, Springer International Publishing, 2019, pp. 217 - 221 [capitolo di libro]
Ferrari S.; Palmerini E., Chemotherapy of Soft Tissue Sarcomas, in: Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - the Rizzoli Case Archive, Switzerland, Springer International Publishing, 2019, pp. 323 - 325 [capitolo di libro]
Pollino S.; Palmerini E.; Dozza B.; Bientinesi E.; Piccinni-Leopardi M.; Lucarelli E.; Righi A.; Benassi M.S.; Pazzaglia L., CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338, «JOURNAL OF BONE ONCOLOGY», 2019, 17, Article number: 100239, pp. 100239 - 100251 [articolo]Open Access
Chawla S.; Blay J.-Y.; Rutkowski P.; Le Cesne A.; Reichardt P.; Gelderblom H.; Grimer R.J.; Choy E.; Skubitz K.; Seeger L.; Schuetze S.M.; Henshaw R.; Dai T.; Jandial D.; Palmerini E., Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study, «THE LANCET ONCOLOGY», 2019, 20, pp. 1719 - 1729 [articolo]
Palmerini E.; Torricelli E.; Cascinu S.; Pierini M.; De Paolis M.; Donati D.; Cesari M.; Longhi A.; Abate M.; Paioli A.; Setola E.; Ferrari S., Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?, «PEDIATRIC BLOOD & CANCER», 2019, 66, Article number: e27792, pp. e27792 - e27797 [articolo]
